Translational Development Acquisition Net Income
| TDAC Stock | USD 10.51 0.03 0.28% |
As of the 15th of February 2026, Translational Development has the Standard Deviation of 0.128, downside deviation of 0.2659, and Risk Adjusted Performance of 0.0022. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Translational Development, as well as the relationship between them.
Translational Development's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Translational Development's valuation are provided below:We have found sixty-nine available fundamental trend indicators for Translational Development Acquisition, which can be analyzed and compared to other ratios and to its competition. Investors should ensure to double-check all of Translational Development's current performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -63.9 K | -67.1 K | |
| Net Loss | -437 K | -458.8 K | |
| Net Loss | (0.02) | (0.02) |
Translational | Net Income | Build AI portfolio with Translational Stock |
Analyzing Translational Development's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Translational Development's current valuation and future prospects.
Latest Translational Development's Net Income Growth Pattern
Below is the plot of the Net Income of Translational Development Acquisition over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Translational Development financial statement analysis. It represents the amount of money remaining after all of Translational Development Acquisition operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Translational Development's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Translational Development's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (71.01 K) | 10 Years Trend |
|
Net Income |
| Timeline |
Translational Net Income Regression Statistics
| Arithmetic Mean | (94,481) | |
| Coefficient Of Variation | (106.68) | |
| Mean Deviation | 46,008 | |
| Median | (70,662) | |
| Standard Deviation | 100,792 | |
| Sample Variance | 10.2B | |
| Range | 421.6K | |
| R-Value | (0.25) | |
| Mean Square Error | 10.2B | |
| R-Squared | 0.06 | |
| Significance | 0.34 | |
| Slope | (4,904) | |
| Total Sum of Squares | 162.5B |
Translational Net Income History
Other Fundumenentals of Translational Development
Translational Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Translational Development is extremely important. It helps to project a fair market value of Translational Stock properly, considering its historical fundamentals such as Net Income. Since Translational Development's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Translational Development's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Translational Development's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Diversified Capital Markets sector continue expanding? Could Translational diversify its offerings? Factors like these will boost the valuation of Translational Development. If investors know Translational will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Translational Development data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Translational Development is measured differently than its book value, which is the value of Translational that is recorded on the company's balance sheet. Investors also form their own opinion of Translational Development's value that differs from its market value or its book value, called intrinsic value, which is Translational Development's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Translational Development's market value can be influenced by many factors that don't directly affect Translational Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Translational Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Translational Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Translational Development's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Translational Development 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Translational Development's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Translational Development.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Translational Development on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Translational Development Acquisition or generate 0.0% return on investment in Translational Development over 90 days. Translational Development is related to or competes with Inflection Point, GigCapital7 Corp, Diamond Hill, M3 Brigade, Axiom Intelligence, and Trailblazer Acquisition. Trident Acquisitions Corp. does not have significant operations More
Translational Development Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Translational Development's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Translational Development Acquisition upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.2659 | |||
| Information Ratio | (0.48) | |||
| Maximum Drawdown | 0.9506 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.1908 |
Translational Development Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Translational Development's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Translational Development's standard deviation. In reality, there are many statistical measures that can use Translational Development historical prices to predict the future Translational Development's volatility.| Risk Adjusted Performance | 0.0022 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | (0.23) | |||
| Treynor Ratio | (0.05) |
Translational Development February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0022 | |||
| Market Risk Adjusted Performance | (0.04) | |||
| Mean Deviation | 0.0636 | |||
| Downside Deviation | 0.2659 | |||
| Coefficient Of Variation | 1462.26 | |||
| Standard Deviation | 0.128 | |||
| Variance | 0.0164 | |||
| Information Ratio | (0.48) | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | (0.23) | |||
| Treynor Ratio | (0.05) | |||
| Maximum Drawdown | 0.9506 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.1908 | |||
| Downside Variance | 0.0707 | |||
| Semi Variance | (0) | |||
| Expected Short fall | (0.20) | |||
| Skewness | 0.8223 | |||
| Kurtosis | 6.79 |
Translational Development Backtested Returns
At this point, Translational Development is very steady. Translational Development owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0957, which indicates the firm had a 0.0957 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Translational Development Acquisition, which you can use to evaluate the volatility of the company. Please validate Translational Development's Risk Adjusted Performance of 0.0022, standard deviation of 0.128, and Downside Deviation of 0.2659 to confirm if the risk estimate we provide is consistent with the expected return of 0.0124%. Translational Development has a performance score of 7 on a scale of 0 to 100. The entity has a beta of 0.023, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Translational Development's returns are expected to increase less than the market. However, during the bear market, the loss of holding Translational Development is expected to be smaller as well. Translational Development right now has a risk of 0.13%. Please validate Translational Development coefficient of variation, sortino ratio, potential upside, as well as the relationship between the jensen alpha and maximum drawdown , to decide if Translational Development will be following its existing price patterns.
Auto-correlation | 0.63 |
Good predictability
Translational Development Acquisition has good predictability. Overlapping area represents the amount of predictability between Translational Development time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Translational Development price movement. The serial correlation of 0.63 indicates that roughly 63.0% of current Translational Development price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.63 | |
| Spearman Rank Test | 0.64 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Translational Development Acquisition reported net income of (71,012). This is 100.01% lower than that of the Capital Markets sector and significantly lower than that of the Financials industry. The net income for all United States stocks is 100.01% higher than that of the company.
Translational Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Translational Development's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Translational Development could also be used in its relative valuation, which is a method of valuing Translational Development by comparing valuation metrics of similar companies.Translational Development is currently under evaluation in net income category among its peers.
Translational Development ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Translational Development's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Translational Development's managers, analysts, and investors.Environmental | Governance | Social |
Translational Fundamentals
| Return On Asset | -0.0064 | ||||
| Current Valuation | 230.3 M | ||||
| Shares Outstanding | 17.25 M | ||||
| Shares Owned By Institutions | 93.49 % | ||||
| Number Of Shares Shorted | 1.87 K | ||||
| Price To Book | 1.33 X | ||||
| EBITDA | (71.01 K) | ||||
| Net Income | (71.01 K) | ||||
| Cash And Equivalents | 972.79 K | ||||
| Cash Per Share | 0.13 X | ||||
| Total Debt | 6.11 T | ||||
| Debt To Equity | 1.01 % | ||||
| Current Ratio | 0.19 X | ||||
| Book Value Per Share | (0.29) X | ||||
| Cash Flow From Operations | (851.45 K) | ||||
| Short Ratio | 0.08 X | ||||
| Earnings Per Share | 0.22 X | ||||
| Beta | 0.1 | ||||
| Market Capitalization | 230.25 M | ||||
| Total Asset | 175 M | ||||
| Retained Earnings | (5.6 M) | ||||
| Working Capital | 439.93 K | ||||
| Net Asset | 175 M |
About Translational Development Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Translational Development Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Translational Development using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Translational Development Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Translational Development is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Translational Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Translational Development Acquisition Stock. Highlighted below are key reports to facilitate an investment decision about Translational Development Acquisition Stock:Check out You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Will Diversified Capital Markets sector continue expanding? Could Translational diversify its offerings? Factors like these will boost the valuation of Translational Development. If investors know Translational will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Translational Development data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Translational Development is measured differently than its book value, which is the value of Translational that is recorded on the company's balance sheet. Investors also form their own opinion of Translational Development's value that differs from its market value or its book value, called intrinsic value, which is Translational Development's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Translational Development's market value can be influenced by many factors that don't directly affect Translational Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Translational Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Translational Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Translational Development's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.